MILLION MARKER WELLNESS INC.
Medtech · Private
Mail-in PFAS blood spot test with personalized actionable report-back for individuals and healthcare providers
- Grants
- $3.0M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Personalized Mobile Intervention to Reduce Exposure to Endocrine Disrupting Chemicals (EDCs) in Women of Child-Bearing Age and their Partners | $218,790 | |
| Federal grant | Department of Health and Human Services · Phase II · A Personalized Digital Intervention Program to Reduce Exposure to Endocrine Disrupting Chemicals among a Child-Bearing Age Cohort | $1,028,322 | |
| Federal grant | Department of Health and Human Services · Phase II · A Personalized Digital Intervention Program to Reduce Exposure to Endocrine Disrupting Chemicals among a Child-Bearing Age Cohort | $796,881 | |
| Federal grant | Department of Health and Human Services · Phase II · A Personalized Digital Intervention Program to Reduce Exposure to Endocrine Disrupting Chemicals among a Child-Bearing Age Cohort | $60,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of an Environmental Health Literacy Mobile Application to Reduce Toxic Environmental Exposures in Black Communities | $272,365 | |
| Federal grant | Department of Health and Human Services · Phase I · Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle interventions to lose weight and reduce EDC exposure in individuals with overweight/obesity | $306,871 | |
| Federal grant | Department of Health and Human Services · Phase I · Reducing rural health disparities by empowering people to minimize PFAS exposure and improve cardiovascular health | $306,871 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1051 | ASC Newcastle LLC | — | $13M |
| 1052 | NEONEUR LLC | — | — |
| 1053 | Peytant Solutions, Inc. | — | $2.6M |
| 1054 | MILLION MARKER WELLNESS INC. | — | — |
| 1055 | BIOMED CONSULTING, INC. | — | — |
| 1056 | INOVODEL, INC. | — | — |
| 1057 | ORTUVO LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.